It inhibits the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-12), modulates the polarization of macrophages towards the M2 (anti-inflammatory) phenotype, and stimulates collagen production in models of pulmonary and cutaneous fibrosis
Also, its growth hormone-stimulating properties make it unsafe for people with active cancer ,27 and its action on the pituitary gland means its unsuitable for people with a pituitary gland disorder
GHK-Cu vs BPC-157: Complete Comparison Guide for Researchers GHK-Cu vs BPC-157 is one of the most common peptide comparisons among researchers interested in tissue repair, recovery, skin regeneration, and general peptide protocol planning
You have a 5 mg vial reconstituted with 2 mL of bacteriostatic water, giving you 2.5 mg/mL
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Feng F., Zhang J., Wang Z., Wu Q., Zhou X
Lilly has said they plan to submit the drug to the FDA for type 2 diabetes approval sometime in 2026